Page last updated: 2024-10-28

hexamethonium and Chronic Pain

hexamethonium has been researched along with Chronic Pain in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.

Research Excerpts

ExcerptRelevanceReference
"Myocardial infarction is the leading cause of death worldwide."1.46Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus. ( Chang, YT; Chen, CC; Chen, WH; Chen, YH; Cheng, YF; Shih, HC; Shyu, BC, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, YF1
Chang, YT1
Chen, WH1
Shih, HC1
Chen, YH1
Shyu, BC1
Chen, CC1

Other Studies

1 other study available for hexamethonium and Chronic Pain

ArticleYear
Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus.
    Nature communications, 2017, 10-10, Volume: 8, Issue:1

    Topics: Animals; Butadienes; Chronic Pain; Disease Models, Animal; Enzyme Inhibitors; Ganglionic Blockers; H

2017